Neuphoria Therapeutics Inc. SEC filings NEUP
Neuphoria Therapeutics Inc. has 420 filings in SEC EDGAR's recent list, going back to Sep 11, 2002. Its latest annual report, Form 10-K, was filed on Sep 18, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, change to shareholder rights). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Oct 23, 2026 | Oct 23, 2026 |
| DEFA14A | Additional proxy material | Sep 18, 2026 | — |
| DEFA14A | Additional proxy material | Sep 18, 2026 | — |
| DEF 14A | Proxy statement | Sep 18, 2026 | Nov 2, 2026 |
| 10-K | Annual report | Sep 18, 2026 | Jun 30, 2026 |
| DEFA14A | Additional proxy material | Jul 24, 2026 | — |
| 8-K |
Current report
Material agreement, Change in control, Regulation FD disclosure
|
Jul 24, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jan 8, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 17, 2025 | Dec 12, 2025 |
| DFAN14A | Filing | Dec 8, 2025 | — |
| DFAN14A | Filing | Dec 8, 2025 | — |
| DEFA14A | Additional proxy material | Dec 8, 2025 | — |
| DEFA14A | Additional proxy material | Dec 4, 2025 | — |
| DFAN14A | Filing | Dec 3, 2025 | — |
| DFAN14A | Filing | Dec 2, 2025 | — |
| DEFA14A | Additional proxy material | Dec 1, 2025 | — |
| DFAN14A | Filing | Nov 26, 2025 | — |
| DFRN14A | Filing | Nov 25, 2025 | — |
| DEFA14A | Additional proxy material | Nov 25, 2025 | — |
| DEFA14A | Additional proxy material | Nov 24, 2025 | — |
| DEFC14A | Filing | Nov 24, 2025 | — |
| DEFC14A | Filing | Nov 24, 2025 | — |
| PREC14A | Filing | Nov 14, 2025 | — |
| 424B5 | Prospectus supplement | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| CORRESP | Letter to the SEC | Nov 12, 2025 | — |
| DEFA14A | Additional proxy material | Nov 12, 2025 | — |
| PREC14A | Filing | Nov 12, 2025 | — |
| DEFA14A | Additional proxy material | Oct 30, 2025 | — |
| DEF 14A | Proxy statement | Oct 30, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Oct 27, 2025 | Oct 27, 2025 |
| 424B5 | Prospectus supplement | Oct 27, 2025 | — |
| 424B5 | Prospectus supplement | Oct 20, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 20, 2025 | Oct 20, 2025 |
| 10-K | Annual report | Sep 29, 2025 | Jun 30, 2025 |
| 424B5 | Prospectus supplement | Sep 23, 2025 | — |
| 8-K |
Current report
Listing notice
|
Sep 16, 2025 | Sep 10, 2025 |
| 424B5 | Prospectus supplement | Jul 29, 2025 | — |
| 8-K |
Current report
Listing notice
|
Jul 18, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Results of operations
|
May 20, 2025 | May 20, 2025 |
| 10-Q | Quarterly report | May 20, 2025 | Mar 31, 2025 |
| NT 10-Q | Notification of late filing | May 15, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Feb 14, 2025 | Dec 31, 2024 |
| 424B5 | Prospectus supplement | Feb 12, 2025 | — |
| 424B5 | Prospectus supplement | Feb 4, 2025 | — |
| EFFECT | Filing | Jan 29, 2025 | — |
| CORRESP | Letter to the SEC | Jan 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2025 | — |
| S-8 | Employee stock plan registration | Jan 28, 2025 | — |
| S-3 | Shelf registration | Jan 24, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 14, 2025 | Jan 10, 2025 |
| EFFECT | Filing | Jan 8, 2025 | — |
| CORRESP | Letter to the SEC | Jan 7, 2025 | — |
| S-3/A | Amendment no. 2 to form s-3 | Jan 7, 2025 | — |
| EFFECT | Filing | Dec 27, 2024 | — |
| EFFECT | Filing | Dec 27, 2024 | — |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Dec 23, 2024 | Dec 23, 2024 |
| POS AM | Post-effective amendment no. 1 to form f-3 | Dec 23, 2024 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Dec 23, 2024 | — |
| 15-12G | Deregistration | Dec 23, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 12, 2024 | Dec 11, 2024 |
| S-3/A | Amendment no. 1 to form s-3 | Nov 25, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2024 | — |
| 8-K |
Current report
Material agreement
|
Nov 21, 2024 | Nov 18, 2024 |
| S-3 | Shelf registration | Nov 18, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Nov 13, 2024 | — |
| DEF 14A | Proxy statement | Nov 12, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Other events
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2024 | Oct 9, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 2, 2024 | Oct 1, 2024 |
| 10-K | Annual report | Sep 30, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 16, 2024 | Jul 11, 2024 |
| EFFECT | Filing | Jun 26, 2024 | — |
| 424B3 | Prospectus | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 24, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Jun 18, 2024 | — |
| 6-K | Current report (foreign issuer) | Jun 3, 2024 | Jun 3, 2024 |
| 6-K | Current report (foreign issuer) | Mar 15, 2024 | Mar 15, 2024 |
| UPLOAD | Letter from the SEC | Jan 18, 2024 | — |
| 20-F/A | Amended annual report (foreign issuer) | Jan 17, 2024 | Jun 30, 2023 |
| CORRESP | Letter to the SEC | Jan 11, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2024 | — |
| 6-K | Current report (foreign issuer) | Jan 4, 2024 | Jan 4, 2024 |
| 6-K | Current report (foreign issuer) | Nov 30, 2023 | Nov 30, 2023 |
| 6-K | Current report (foreign issuer) | Nov 28, 2023 | Nov 28, 2023 |
| 6-K | Current report (foreign issuer) | Nov 3, 2023 | Nov 3, 2023 |
| 20-F | Annual report (foreign issuer) | Oct 18, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Oct 16, 2023 | Oct 16, 2023 |
| 6-K | Current report (foreign issuer) | Sep 29, 2023 | Sep 29, 2023 |
| 6-K | Current report (foreign issuer) | Sep 28, 2023 | Sep 28, 2023 |
| 6-K | Current report (foreign issuer) | Jul 31, 2023 | Jul 31, 2023 |
| 6-K | Current report (foreign issuer) | Jul 28, 2023 | Jul 28, 2023 |
| 6-K | Current report (foreign issuer) | Jul 25, 2023 | Jul 25, 2023 |
| 6-K | Current report (foreign issuer) | Jul 24, 2023 | Jul 24, 2023 |
| 6-K | Current report (foreign issuer) | Jul 7, 2023 | Jul 7, 2023 |
| 6-K | Current report (foreign issuer) | Jul 7, 2023 | Apr 28, 2023 |
| 6-K | Current report (foreign issuer) | Jul 3, 2023 | Jul 3, 2023 |
| EFFECT | Filing | May 17, 2023 | — |
| CORRESP | Letter to the SEC | May 15, 2023 | — |
| UPLOAD | Letter from the SEC | May 11, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | May 5, 2023 | — |
| 6-K | Current report (foreign issuer) | Apr 27, 2023 | Apr 27, 2023 |
| 6-K | Current report (foreign issuer) | Mar 9, 2023 | Mar 9, 2023 |
| 6-K | Current report (foreign issuer) | Feb 23, 2023 | Feb 23, 2023 |
| 6-K | Current report (foreign issuer) | Feb 23, 2023 | Feb 23, 2023 |
| 6-K | Current report (foreign issuer) | Feb 21, 2023 | Feb 21, 2023 |
| 6-K | Current report (foreign issuer) | Jan 30, 2023 | Jan 30, 2023 |
| 6-K | Current report (foreign issuer) | Jan 18, 2023 | Jan 18, 2023 |
| 6-K | Current report (foreign issuer) | Jan 9, 2023 | Jan 9, 2023 |
| 6-K | Current report (foreign issuer) | Dec 19, 2022 | Dec 19, 2022 |
| 6-K | Current report (foreign issuer) | Dec 16, 2022 | Dec 16, 2022 |
| 424B4 | Prospectus | Nov 18, 2022 | — |
| EFFECT | Filing | Nov 16, 2022 | — |
| F-1MEF | Filing | Nov 16, 2022 | — |
| 6-K | Current report (foreign issuer) | Nov 16, 2022 | Nov 16, 2022 |
| CORRESP | Letter to the SEC | Nov 14, 2022 | — |
| CORRESP | Letter to the SEC | Nov 14, 2022 | — |
| F-1/A | Filing | Nov 14, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Nov 10, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2022 | — |
| DRS | Filing | Oct 31, 2022 | — |
| 6-K | Current report (foreign issuer) | Oct 25, 2022 | Oct 25, 2022 |
| 6-K | Current report (foreign issuer) | Oct 18, 2022 | Oct 18, 2022 |
| 6-K | Current report (foreign issuer) | Oct 18, 2022 | Oct 18, 2022 |
| 20-F | Annual report (foreign issuer) | Oct 14, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Oct 6, 2022 | Oct 6, 2022 |
| 6-K | Current report (foreign issuer) | Oct 4, 2022 | Oct 4, 2022 |
| 6-K | Current report (foreign issuer) | Sep 21, 2022 | Sep 21, 2022 |
| 6-K | Current report (foreign issuer) | Aug 25, 2022 | Aug 25, 2022 |
| 6-K | Current report (foreign issuer) | Aug 8, 2022 | Aug 8, 2022 |
| 6-K | Current report (foreign issuer) | Jul 29, 2022 | Jul 29, 2022 |
| 6-K | Current report (foreign issuer) | Jul 20, 2022 | Jul 20, 2022 |
| 6-K | Current report (foreign issuer) | Jul 5, 2022 | Jul 5, 2022 |
| 6-K | Current report (foreign issuer) | Jun 13, 2022 | Jun 13, 2022 |
| 6-K | Current report (foreign issuer) | May 18, 2022 | May 18, 2022 |
| 6-K | Current report (foreign issuer) | May 16, 2022 | May 16, 2022 |
| 6-K | Current report (foreign issuer) | Apr 29, 2022 | Apr 29, 2022 |
| 6-K | Current report (foreign issuer) | Feb 23, 2022 | Jan 31, 2022 |
| 6-K | Current report (foreign issuer) | Jan 28, 2022 | Jan 28, 2022 |
| 6-K | Current report (foreign issuer) | Jan 12, 2022 | Jan 12, 2022 |
| 6-K | Current report (foreign issuer) | Jan 4, 2022 | Jan 4, 2022 |
| 6-K | Current report (foreign issuer) | Jan 3, 2022 | Jan 3, 2022 |
| 6-K | Current report (foreign issuer) | Dec 22, 2021 | Dec 22, 2021 |
| S-8 | Employee stock plan registration | Dec 21, 2021 | — |
| 424B4 | Prospectus | Dec 17, 2021 | — |
| EFFECT | Filing | Dec 15, 2021 | — |
| EFFECT | Filing | Dec 15, 2021 | — |
| CORRESP | Letter to the SEC | Dec 15, 2021 | — |
| CORRESP | Letter to the SEC | Dec 15, 2021 | — |
| CERT | Filing | Dec 14, 2021 | — |
| CORRESP | Letter to the SEC | Dec 13, 2021 | — |
| CORRESP | Letter to the SEC | Dec 13, 2021 | — |
| 8-A12B | Filing | Dec 13, 2021 | — |
| F-1/A | Filing | Dec 13, 2021 | — |
| F-6 | Filing | Dec 10, 2021 | — |
| CORRESP | Letter to the SEC | Dec 8, 2021 | — |
| F-1/A | Filing | Dec 8, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2021 | — |
| CORRESP | Letter to the SEC | Nov 22, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Nov 22, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2021 | — |
| DRS/A | Filing | Oct 28, 2021 | — |
| DRSLTR | Filing | Oct 27, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2021 | — |
| DRS | Filing | Sep 10, 2021 | — |
| D | Filing | Sep 27, 2012 | — |
| SUPPL | Auto-generated paper document | Jan 27, 2009 | — |
| SUPPL | Auto-generated paper document | Dec 30, 2008 | — |
| SUPPL | Auto-generated paper document | Dec 1, 2008 | — |
| SUPPL | Auto-generated paper document | Nov 21, 2008 | — |
| SUPPL | Auto-generated paper document | Nov 14, 2008 | — |
| SUPPL | Auto-generated paper document | Oct 20, 2008 | — |
| SUPPL | Auto-generated paper document | Sep 26, 2008 | — |
| SUPPL | Auto-generated paper document | Sep 22, 2008 | — |
| SUPPL | Auto-generated paper document | Sep 15, 2008 | — |
| SUPPL | Auto-generated paper document | Sep 2, 2008 | — |
| SUPPL | Auto-generated paper document | Aug 18, 2008 | — |
| SUPPL | Auto-generated paper document | Aug 11, 2008 | — |
| SUPPL | Auto-generated paper document | Jul 28, 2008 | — |
| ARS | Annual report to shareholders | Jul 23, 2008 | Jun 30, 2007 |
| SUPPL | Auto-generated paper document | Jul 21, 2008 | — |
| SUPPL | Auto-generated paper document | Jul 21, 2008 | — |
| SUPPL | Auto-generated paper document | Apr 28, 2008 | — |
| SUPPL | Auto-generated paper document | Feb 14, 2008 | — |
| SUPPL | Auto-generated paper document | Sep 7, 2007 | — |
| SUPPL | Auto-generated paper document | Jun 26, 2007 | — |
| SUPPL | Auto-generated paper document | Jun 18, 2007 | — |
| SUPPL | Auto-generated paper document | Jun 12, 2007 | — |
| SUPPL | Auto-generated paper document | Jun 8, 2007 | — |
| SUPPL | Auto-generated paper document | May 7, 2007 | — |
| SUPPL | Auto-generated paper document | May 1, 2007 | — |
| SUPPL | Auto-generated paper document | Apr 30, 2007 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NEUP (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Burlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1191070
- Former names
- BIONOMICS LIMITED/FI (until Dec 23, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.